Charged particle radiation therapy for uveal melanoma: A systematic review and meta-analysis

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 1, 2013, Pages 18-26

  Wang, Zhen ^a   Nabhan, Mohammed ^a   Schild, Steven E ^b   Stafford, Scott L ^a   Petersen, Ivy A ^a   Foote, Robert L ^a   Murad, M Hassan ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATARACT FORMATION; COCHRANE DATABASE; COMPARATIVE EFFECTIVENESS; CONFIDENCE INTERVAL; OBSERVATIONAL STUDY; PARTICLE RADIATION THERAPIES; SIGNIFICANT DIFFERENCES; SYSTEMATIC REVIEW;

CARBON; DERMATOLOGY; EYE PROTECTION; IONS; PROTONS; RADIOTHERAPY;

ONCOLOGY;

HELIUM; PROTON;

BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CATARACT; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; CONFIDENCE INTERVAL; DATA EXTRACTION; EMBASE; ENUCLEATION; HUMAN; ION THERAPY; MEDLINE; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINOPATHY; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UVEA MELANOMA;

EYE ENUCLEATION; HEAVY ION RADIOTHERAPY; HELIUM; HUMANS; MELANOMA; PROTON THERAPY; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 84876141172     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.08.026     Document Type: Review

References (55)

1. J.M. Quivey, J. Augsburger, and L. Snelling [125]I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control Cancer 77 1996 2356 2362
2. J.M. Seddon, E.S. Gragoudas, and K.M. Egan Relative survival rates after alternative therapies for uveal melanoma Ophthalmology 97 1990 769 777 (Pubitemid 20183280)
3. D.M. Robertson, J. Earle, and J.A. Anderson Preliminary observations regarding the use of iodine-125 in the management of choroidal melanoma Trans Ophthalmol Soc U K 103 pt 2 1983 155 160 (Pubitemid 14188023)
4. S. Packer, M. Rotman, and P. Salanitro Iodine-125 irradiation of choroidal melanoma. Clinical experience Ophthalmology 91 1984 1700 1708 (Pubitemid 15197050)
5. M. Diener-West, J.D. Earle, and S.L. Fine The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. III. Initial mortality findings. COMS report no. 18 Arch Ophthalmol 119 2001 969 982
6. M. Diener-West, J.D. Earle, and S.L. Fine The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. II. characteristics of patients enrolled and not enrolled. COMS report no. 17 Arch Ophthalmol 119 2001 951 965
7. E. Egger, L. Zografos, and A. Schalenbourg Eye retention after proton beam radiotherapy for uveal melanoma Int J Radiat Oncol Biol Phys 55 2003 867 880 (Pubitemid 36286989)
8. D. Moher, A. Liberati, and J. Tetzlaff Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269 W264
9. G.E. Bekkering, A.W. Rutjes, and V.V. Vlassov The effectiveness and safety of proton radiation therapy for indications of the eye: a systematic review Strahlenther Onkol 185 2009 211 221
10. T. Terasawa, T. Dvorak, and S. Ip Systematic review: charged-particle radiation therapy for cancer Ann Intern Med 151 2009 556 565
11. J.P.T. Higgins, and S. Green Cochrane Handbook for Systematic Reviews of Interventions 2008 Wiley-Blackwell Hoboken, NJ
12. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analysis. Ottawa, Ontario (Canada): The Ottawa Health Research Institute.
13. N. Freemantle, J. Cleland, and P. Young beta Blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737 (Pubitemid 29290470)
14. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
15. M. Egger, G. Davey Smith, and M. Schneider Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634 (Pubitemid 27387172)
16. Collaborative Ocular Melanoma Study Group The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. V. Twelve-year mortality rates and prognostic factors: COMS report No. 28 Arch Ophthalmol 124 2006 1684 1693
17. L.M. Jampol, C.S. Moy, and T.G. Murray The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19 Ophthalmology 109 2002 2197 2206 (Pubitemid 35417099)
18. M. Diener-West, S.M. Reynolds, and D.J. Agugliaro Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group report no. 26 Arch Ophthalmol 123 2005 1639 1643 (Pubitemid 41785095)
19. B.R. Straatsma, S.L. Fine, and J.D. Earle Enucleation versus plaque irradiation for choroidal melanoma Ophthalmology 95 1988 1000 1004
20. D.H. Char, J.M. Quivey, and J.R. Castro Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial Ophthalmology 100 1993 1547 1554 (Pubitemid 23292865)
21. E.S. Gragoudas, A.M. Lane, and S. Regan A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma Arch Ophthalmol 118 2000 773 778 (Pubitemid 30395173)
22. L. Desjardins, L. Lumbroso-Le Rouic, and C. Levy-Gabriel Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients Ophthalmic Res 38 2006 255 260 (Pubitemid 44492173)
23. C. Mosci, F.B. Lanza, and A. Barla Comparison of clinical outcomes for patients with large choroidal melanoma after primary treatment with enucleation or proton beam radiotherapy Ophthalmologica 227 2012 190 196
24. L. Marucci, M. Ancukiewicz, and A.M. Lane Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation Int J Radiat Oncol Biol Phys 79 2011 842 846
25. I. Puusaari, J. Heikkonen, and T. Kivela Ocular complications after iodine brachytherapy for large uveal melanomas Ophthalmology 111 2004 1768 1777 (Pubitemid 39179695)
26. H.C. Boldt, B.M. Melia, and J.C. Liu I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS report no. 30 Ophthalmology 116 2009 106 115
27. Collaborative Ocular Melanoma Study Group Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS report no. 27 Ophthalmology 114 2007 1363 1371
28. N.E. Bechrakis, G. Blatsios, and E. Schmid Surgical resection techniques of large uveal melanomas Spektrum Augenheilkd 24 2010 17 22
29. S. Aziz, A. Taylor, and A. McConnachie Proton beam radiotherapy in the management of uveal melanoma: clinical experience in Scotland Clin Ophthalmol 3 2009 48 55
30. A.M. Lane, I.K. Kim, and E.S. Gragoudas Proton irradiation for peripapillary and parapapillary melanomas Arch Ophthalmol 129 2011 1127 1130
31. I.K. Kim, A.M. Lane, and K.M. Egan Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma Ophthalmology 117 2010 1617 1622
32. C.L. Shields, M. Furuta, and A. Thangappan Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes Arch Ophthalmol 127 2009 989 998
33. P.T. Finger, K.J. Chin, and L.B. Tena Finger's slotted plaque brachytherapy for peripapillary, juxtapapillary and circumpapillary choroidal melanoma Int J Radiat Oncol Biol Phys 81 2011 S296-S296
34. N. Khan, M.K. Khan, and J. Bena Factors predictive of developing radiation retinopathy (RR) and vision loss following plaque brachytherapy for uveal melanoma Int J Radiat Oncol Biol Phys 81 2011 S295 S296
35. S. Garg, S. Reich, and B. Gielda Prognostic factors in patients with choroidal melanoma treated with iodine 125 brachytherapy Int J Radiat Oncol Biol Phys 81 2011 S685 S686
36. H. Balshem, M. Helfand, and H.J. Schunemann GRADE guidelines. 3. Rating the quality of evidence J Clin Epidemiol 64 2011 401 406
37. G.H. Guyatt, A.D. Oxman, and G. Vist GRADE guidelines. 4. Rating the quality of evidence-study limitations (risk of bias) J Clin Epidemiol 64 2011 407 415
38. N.V. Shah, S.K. Houston, and T.G. Murray Evaluation of the surgical learning curve for I-125 episcleral plaque placement for the treatment of posterior uveal melanoma: a two decade review Clin Ophthalmol 6 2012 447 452
39. C. Bellmann, L. Lumbroso-Le Rouic, and C. Levy Uveal melanoma: management and outcome of patients with extraocular spread Br J Ophthalmol 94 2010 569 574
40. D.H. Char, S. Kroll, and J.M. Quivey Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy Br J Ophthalmol 80 1996 117 124 (Pubitemid 26058543)
41. D.H. Char, R. Bove, and T.L. Phillips Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments Am J Ophthalmol 136 2003 180 182 (Pubitemid 36794514)
42. J.W. Harbour, D.H. Char, and S. Kroll Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma Ophthalmology 104 1997 1785 1792 discussion 1792-1783
43. M.W. Wilson, and J.L. Hungerford Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma Ophthalmology 106 1999 1579 1587 (Pubitemid 30214359)
44. D. Vavvas, I. Kim, and A.M. Lane Posterior uveal melanoma in young patients treated with proton beam therapy Retina 30 2010 1267 1271
45. J.-P. Caujolle, H. Mammar, and E. Chamorey Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience Int J Radiat Oncol Biol Phys 78 2010 98 103
46. Cirrone GAP, Cuttone G, Rosa FD, et al. Dosimetric and clinical experience in eye proton treatment at INFN-LNS. Perspective in nuclear physics: proceedings of the 6th Japan-Italy Symposium on Heavy-Ion Physics. Vol 1120. Tokai; 2009. pp. 221-226.
47. I.K. Daftari, K.K. Mishra, and J.M. O'Brien Fundus image fusion in EYEPLAN software: an evaluation of a novel technique for ocular melanoma radiation treatment planning Med Phys 37 2010 5199 5207
48. L. Desjardins, L. Lumbroso-Le Rouic, and C. Levy-Gabriel Treatment of uveal melanoma by accelerated proton beam Dev Ophthalmol 49 2012 41 57
49. E. Khan, F. Maréchal, and R. Dendale Anomalous phosphenes in ocular protontherapy Adv Space Res 45 2010 846 849
50. E.C.A. Macdonald, P. Cauchi, and E.G. Kemp Proton beam therapy for the treatment of uveal melanoma in Scotland Br J Ophthalmol 95 2011 1691 1695
51. A. Mizota Ophthalmic tumor and carbon ion irradiation. [In Japanese] Teikyo Med J 33 2010 131 143
52. C. Mosci, S. Mosci, and A. Barla Proton beam radiotherapy of uveal melanoma: Italian patients treated in Nice, France Eur J Ophthalmol 19 2009 654 660
53. K. Tamura, K. Yoshikawa, and H. Ishikawa Carbon-11-methionine PET imaging of choroidal melanoma and the time course after carbon ion beam radiotherapy Anticancer Res 29 2009 1507 1514
54. E. Tran, R. Ma, and K. Paton Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC Cancer Agency Int J Radiat Oncol Biol Phys 83 2012 1425 1431
55. N.E. Bechrakis, E. Schmid, and G. Blatsios Proton beam irradiation of uveal melanomas of the posterior pole Spektrum der Augenheilkunde 24 2010 11 16